Submit Manuscript now
Impact Factor 4.452

Research Article

Acute Pancreatitis as First Manifestation of Severe Hypothyroidism: A Rare Case Report

Leave a Comment / Issue 1 Articles, Volume 9 / By

1. Abstract We described the case of a 34-year-old Bangladeshi man with an unremarkable personal and family history who presented to the emergency department with severe upper abdominal pain of one day’s duration and with elevated serum amylase and lipase. Further work-up revealed a serum triglyceride level of 39.8 mmol/L and his thyroid function test …

Acute Pancreatitis as First Manifestation of Severe Hypothyroidism: A Rare Case Report Read More »

Anti Hcv Antibody Merits Proper Interpretation

Leave a Comment / Issue 1 Articles, Volume 9 / By

1. Abstract 1.1. Introduction: Chronic Hepatitis C Virus (HCV) infection, a leading cause of liver cirrhosis, causes significant morbidity and mortality and has become an important indication for liver transplantation all over the world. The initial treatment was with Pegylated Interferon and Ribavarin but later on wide availability of oral Directly Acting Antiviral (DAA) drugs …

Anti Hcv Antibody Merits Proper Interpretation Read More »

Registry to Understand Patient Characteristics, Treatment Patterns, and Therapy Outcomes in Adults with Chronic Hepatitis C Virus Infection in Asia, Africa, and Eastern Europe

Leave a Comment / Issue 1 Articles, Volume 9 / By

1. Abstract 1.1. Background: Several patient, government, payer, and provider-level barriers to Hepatitis C virus (HCV) treatment have been identified in regions like Asia, Africa, and the Commonwealth of Independent States (CIS). A patient registry was created in these regions to understand the patterns of clinical care and outcomes in real-world settings.

Self-expandable Metallic Stents for the Palliation of Malignant Growth of Esophagus

Leave a Comment / Issue 1 Articles, Volume 9 / By

1. Abstract 1.1. Background: Often patients with carcinomas of esophagus presents with dysphagia at a late stage where curative treatments are not a treatment option. To relieve dysphagia and its consequences palliative esophageal stentings are offered. Self-expanding metal stents (SEMS) and self-expanding plastic stents (SEPS) are available for reliving the dysphagia. Uncovered, partially covered, or …

Self-expandable Metallic Stents for the Palliation of Malignant Growth of Esophagus Read More »

Effects of Targeting NRF2 on Inhibiting Gastric Cancer Growth and Tumor Development in Vitro and in Vivo

Leave a Comment / Issue 1 Articles, Volume 9 / By

1. Abstract 1.1. Background: Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) is a transcription factor that regulates the expression of the cellular antioxidant response. Traditionally, Nrf2 is regarded as a tumor suppressor owing to its characteristic which prevents oxidative or electrophilic insult. However, there is increasing evidence that Nrf2 is activated in malignant cells. At …

Effects of Targeting NRF2 on Inhibiting Gastric Cancer Growth and Tumor Development in Vitro and in Vivo Read More »

Network Meta-Analysis of Hepatic Arterial Infusion Versus Selective Internal Radiation Therapy for Colorectal Cancer Liver Metastasis

Leave a Comment / Issue 1 Articles, Volume 9 / By

1. Abstract 1.1. Background: Colorectal cancer liver metastases (CRLM) that cannot be surgically removed are often addressed locally with Hepatic Arterial Infusion (HAI) or Selective Internal Radiation Therapy (SIRT). This study used Bayesian network meta-analysis (NMA) to assess the differences in survival between patients treated with HAI or SIRT for CRLM.

Network Meta-Analysis of Hepatic Arterial Infusion Versus Selective Internal Radiation Therapy for Colorectal Cancer Liver Metastasis

Leave a Comment / Issue 1 Articles, Volume 9 / By

1. Abstract 1.1. Background: Colorectal cancer liver metastases (CRLM) that cannot be surgically removed are often addressed locally with Hepatic Arterial Infusion (HAI) or Selective Internal Radiation Therapy (SIRT). This study used Bayesian network meta-analysis (NMA) to assess the differences in survival between patients treated with HAI or SIRT for CRLM.

Hepcidin, Ferroportin and Hephaestin Levels in Inflammatory Bowel Disease; Are they Key Mediators of Anemia or Inflammation?

Leave a Comment / Issue 1 Articles, Volume 9 / By

1. Abstract 1.1. Background: Anemia represents a significant problem in Inflammatory Bowel Disease (IBD) and diagnosis may be challenging due to inflammation. Hepcidin, ferroportin and hephaestin are novel Iron Regulatory Proteins (IRPs) involved in iron metabolism. This study aimed to identify the interactions of these proteins in IBD patients, guiding safe iron supplementation and effective …

Hepcidin, Ferroportin and Hephaestin Levels in Inflammatory Bowel Disease; Are they Key Mediators of Anemia or Inflammation? Read More »

What Our Author Say's

I am glad that I found this platform. It was easy to get my research published and I was guided at every step. I highly recommend them.
Shuang-Qin Yi
am grateful to the Japanese Journal of Gastroenterology and Hepatology for helping me with my research and publishing it. Looking forward to more work with them.
Makki Fayadh
It has been a pleasure working with the Japanese Journal of Gastroenterology and Hepatology. They have been amazing in helping me with my manuscript
Han Min
I am glad that I submitted my manuscript here. They helped me make necessary edits and published the best version of it. I highly recommend them.
Sadaf Saleem

FAQ's About Jajgastrohepto

The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.

For Detailed quotations reach out submission@jajogh.jp

It depends on the length of the manuscript and the reviews and edits needed.

We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.

A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.

Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.

*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.

Copyright 2018-2024 All Rights Reserved.